Diabetic cardiomyopathy: the search for a unifying hypothesis.
暂无分享,去创建一个
[1] H. Huikuri,et al. Echocardiographic evaluation of left ventricular response to isometric exercise in young insulin-dependent diabetics , 1986, Acta diabetologia latina.
[2] C. R. Wilson,et al. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. , 2005, American journal of physiology. Endocrinology and metabolism.
[3] E. Abel,et al. Akt1 in the cardiovascular system: friend or foe? , 2005, The Journal of clinical investigation.
[4] A. Bonen,et al. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. , 2005, American journal of physiology. Heart and circulatory physiology.
[5] J. Born,et al. Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia. , 2005, Metabolism: clinical and experimental.
[6] A. Marette,et al. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. , 2005, Endocrinology.
[7] J. Huss,et al. Mitochondrial energy metabolism in heart failure: a question of balance. , 2005, The Journal of clinical investigation.
[8] G. Condorelli,et al. Akt Mediates the Cross-Talk Between &bgr;-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes , 2005, Circulation research.
[9] Xianlin Han,et al. Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy , 2005, Circulation research.
[10] D. Raev. Left ventricular function and specific diabetic complications in other target organs in young insulin-dependent diabetics: An echocardiographic study , 2005, Heart and Vessels.
[11] J. Carvalheira,et al. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway , 2005, Diabetologia.
[12] R. Pop-Busui,et al. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. , 2004, Journal of the American College of Cardiology.
[13] A. Schmermund,et al. Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine‐stimulated coronary flow response in human subjects , 2004, Clinical endocrinology.
[14] M. Cooper,et al. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. , 2004, American journal of hypertension.
[15] V. Rajapurohitam,et al. Rat heart is a site of leptin production and action. , 2004, American journal of physiology. Heart and circulatory physiology.
[16] B. Manning. Balancing Akt with S6K , 2004, The Journal of cell biology.
[17] B. Draznin,et al. Molecular mechanisms of insulin resistance that impact cardiovascular biology. , 2004, Diabetes.
[18] T. Hunter,et al. Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies , 2004, Current Biology.
[19] G. Grassi. Counteracting the sympathetic nervous system in essential hypertension , 2004, Current opinion in nephrology and hypertension.
[20] R. Cooksey,et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. , 2004, Diabetes.
[21] C. Yosefy,et al. Rosiglitazone Improves, While Glibenclamide Worsens Blood Pressure Control in Treated Hypertensive Diabetic and Dyslipidemic Subjects via Modulation of Insulin Resistance and Sympathetic Activity , 2004, Journal of cardiovascular pharmacology.
[22] Thomas H Marwick,et al. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.
[23] Ernest Adeghate,et al. Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review , 2004, Molecular and Cellular Biochemistry.
[24] A. Avogaro,et al. Early myocardial dysfunction in the diabetic heart: current research and clinical applications. , 2004, The American journal of cardiology.
[25] A. Avogaro,et al. Diabetic cardiomyopathy: a metabolic perspective. , 2004, The American journal of cardiology.
[26] P. Bruneval,et al. High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[27] Ren-Ke Li,et al. Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways. , 2004, Endocrinology.
[28] A. Lochner,et al. The effects of insulin and β-adrenergic stimulation on glucose transport, glut 4 and PKB activation in the myocardium of lean and obese non-insulin dependent diabetes mellitus rats , 2001, Molecular and Cellular Biochemistry.
[29] A. Luchner,et al. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[30] M. Karmazyn,et al. Heme oxygenase in diabetes-induced oxidative stress in the heart. , 2003, Journal of molecular and cellular cardiology.
[31] E. Schwammenthal,et al. Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus , 2003, Cardiovascular diabetology.
[32] M. Fukuda,et al. Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation* , 2003, Journal of Biological Chemistry.
[33] R. Ramasamy. Aldose reductase: a novel target for cardioprotective interventions. , 2003, Current drug targets.
[34] A. Criollo,et al. Aldose Reductase Induced by Hyperosmotic Stress Mediates Cardiomyocyte Apoptosis , 2003, Journal of Biological Chemistry.
[35] A. Bertoni,et al. Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. , 2003, Diabetes care.
[36] L. Rossetti,et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.
[37] E. Abel,et al. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. , 2003, American journal of physiology. Heart and circulatory physiology.
[38] L. Kirshenbaum,et al. The Obesity-Associated Peptide Leptin Induces Hypertrophy in Neonatal Rat Ventricular Myocytes , 2003, Circulation research.
[39] E. Picano. Diabetic cardiomyopathy. the importance of being earliest. , 2003, Journal of the American College of Cardiology.
[40] W. Merkle,et al. Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil , 2003, Cardiovascular diabetology.
[41] Mu Wang,et al. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. , 2003, Diabetes.
[42] Merlin C. Thomas,et al. A Breaker of Advanced Glycation End Products Attenuates Diabetes‐Induced Myocardial Structural Changes , 2003, Circulation research.
[43] P. McNulty. Insulin resistance and cardiac mass: the end of the beginning? , 2003, Obesity research.
[44] F. Leonetti,et al. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. , 2003, Obesity research.
[45] Andrew D McCulloch,et al. Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy. , 2003, American journal of physiology. Heart and circulatory physiology.
[46] Y. Sugisaki,et al. Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart. , 2003, Experimental and molecular pathology.
[47] D. Levy,et al. Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study , 2003, Circulation.
[48] S. Yuan,et al. Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. , 2003, Physiological genomics.
[49] J. Hare,et al. Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice , 2002, Circulation.
[50] M. Kohno,et al. Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats. , 2002, Cardiovascular research.
[51] J. R. Wu-wong,et al. Endothelin-stimulated glucose uptake: effects of intracellular Ca(2+), cAMP and glucosamine. , 2002, Clinical science.
[52] G. Lopaschuk,et al. Leptin Activates Cardiac Fatty Acid Oxidation Independent of Changes in the AMP-activated Protein Kinase-Acetyl-CoA Carboxylase-Malonyl-CoA Axis* , 2002, The Journal of Biological Chemistry.
[53] P. Razeghi,et al. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. , 2002, Diabetes.
[54] J. Chatham,et al. Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. , 2002, Cardiovascular research.
[55] B. Howard,et al. Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. , 2002, Diabetes.
[56] K. Clarke,et al. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. , 2002, Diabetes.
[57] 阿部 毅寿. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats , 2002 .
[58] Xianlin Han,et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.
[59] B. Hemmings,et al. Ten years of protein kinase B signalling: a hard Akt to follow. , 2001, Trends in biochemical sciences.
[60] A. Marette,et al. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. , 2001, The Journal of biological chemistry.
[61] J. Robbins,et al. The Tumor Suppressor Gene PTEN Can Regulate Cardiac Hypertrophy and Survival* , 2001, The Journal of Biological Chemistry.
[62] M. Birnbaum. Turning down insulin signaling. , 2001, The Journal of clinical investigation.
[63] D R Alessi,et al. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.
[64] G. Shulman,et al. Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.
[65] A. Clerk,et al. Akt like a woman: gender differences in susceptibility to cardiovascular disease. , 2001, Circulation research.
[66] Mark A Sussman,et al. Myocardial Akt Activation and Gender: Increased Nuclear Activity in Females Versus Males , 2001, Circulation research.
[67] Gongxin Liu,et al. Long-Chain Acyl-Coenzyme A Esters and Fatty Acids Directly Link Metabolism to KATP Channels in the Heart , 2001, Circulation research.
[68] Roy Taylor,et al. Effects of Tumor Necrosis Factor-α on Insulin Action in Cultured Human Muscle Cells , 2001 .
[69] R. Fryer,et al. Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats , 2001, Basic Research in Cardiology.
[70] G. Francis,et al. Diabetic cardiomyopathy: fact or fiction? , 2001, Heart.
[71] J. Gardin,et al. Importance of heart failure with preserved systolic function in patients ≥65 years of age , 2001 .
[72] J. Gardin,et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. , 2001, The American journal of cardiology.
[73] J. Mccormack,et al. Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. , 2001, Diabetes.
[74] L. Orci,et al. Lipotoxic diseases of nonadipose tissues in obesity , 2000, International Journal of Obesity.
[75] D. Severson,et al. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. , 2000, American journal of physiology. Endocrinology and metabolism.
[76] J. Sowers,et al. Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. , 2000, American journal of physiology. Heart and circulatory physiology.
[77] T. Nishikawa,et al. The missing link: a single unifying mechanism for diabetic complications. , 2000, Kidney international. Supplement.
[78] L. Mansi,et al. Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study. , 2000, Journal of the American College of Cardiology.
[79] K. Ohtomo,et al. Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[80] P. McDonagh,et al. Microvascular Perfusion and Transport in the Diabetic Heart , 2000, Microcirculation.
[81] H. Taegtmeyer,et al. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. , 2000, Journal of molecular and cellular cardiology.
[82] G. Condorelli,et al. The Akt-Glycogen Synthase Kinase 3β Pathway Regulates Transcription of Atrial Natriuretic Factor Induced by β-Adrenergic Receptor Stimulation in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.
[83] Simon Stewart,et al. Epidemiology, aetiology, and prognosis of heart failure , 2000, Heart.
[84] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[85] G. Shulman,et al. On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .
[86] G. Paolisso,et al. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. , 1999, Hypertension.
[87] G. King,et al. Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.
[88] G. King,et al. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[89] B. Rodrigues,et al. Myocardial substrate metabolism: implications for diabetic cardiomyopathy. , 1995, Journal of molecular and cellular cardiology.
[90] D. Levy,et al. The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.
[91] H. Reinauer,et al. Different types of postinsulin receptor defects contribute to insulin resistance in hearts of obese Zucker rats. , 1986, Endocrinology.
[92] J. McNeill,et al. Diabetes-induced abnormalities in the myocardium. , 1986, Life sciences.
[93] J. McNeill,et al. A Functional and Ultrastructural Analysis of Experimental Diabetic Rat Myocardium: Manifestation of a Cardiomyopathy , 1985, Diabetes.
[94] N. Dhalla,et al. Pathogenesis of cardiac dysfunction in diabetes mellitus. , 1985, The Canadian journal of cardiology.
[95] C. F. Pilati,et al. Left ventricular function of the isolated, genetically obese rat's heart. , 1985, The American journal of physiology.
[96] J. McNeill,et al. The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance. , 1982, Canadian journal of physiology and pharmacology.
[97] E. Sonnenblick,et al. The Effect of Streptozotocin‐Induced Diabetes in Rats on Cardiac Contractile Proteins , 1981, Circulation research.
[98] E. Sonnenblick,et al. Reversibility of Diabetic Cardiomyopathy with Insulin in Rats , 1981, Circulation research.
[99] W. Kannel,et al. Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.